UPPER CHESAPEAKE MEDICAL CENTER — History
CCN 210049 | 3-year financial timeline | COVID resilience: 68/100
🛡️ Public data only — no PHI permitted on this instance.
$320M
Latest Revenue (FY2022)
+3.6%
Revenue CAGR (3yr)
2.5%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $298M | $321M | $320M | -0.2% | +3.6% |
| Operating Expenses | $285M | $307M | $312M | +1.8% | +4.7% |
| Operating Margin | 4.5% | 4.5% | 2.5% | -43.0% | -24.9% |
| Net Income | $13M | $14M | $8M | -43.2% | -22.2% |
| Licensed Beds | 161 | 161 | 202 | +25.5% | +12.0% |
| Total Patient Days | 53,232 | 54,697 | 57,329 | +4.8% | +3.8% |
| Medicare Day % | 50% | 48% | 50% | +4.1% | -0.6% |
| Medicaid Day % | 4% | 4% | 4% | -3.7% | -7.3% |
COVID Impact & Recovery
Resilience Score: 68/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +7.4% ($298M → $320M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▲ Growing
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+3.6%
This Hospital
+7.6%
State Avg
Latest Margin
2.5%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $331M | 1.6% |
| FY2024 (proj) | $342M | 0.6% |
| FY2025 (proj) | $353M | -0.4% |